ÂÜÀòÂÒÂ×

Julien Daubriac is a highly experienced Principal Scientist currently at Recursion since November 2024, with prior extensive roles at Exscientia and Oncodesign managing teams in oncology and in vitro sciences. Julien has a strong background in leading scientific teams and conducting critical research across various organizations, including Inventiva Pharma, Almac Discovery, and academic institutions such as New York University and Harvard Medical School. With a Doctor of Philosophy in Toxicology from Université Paris Cité and a comprehensive educational foundation in biochemistry and molecular biology, Julien has contributed to significant advancements in cancer research and compound profiling throughout a career spanning over 15 years.